| 1Infliximab |
|---|
search
Applications
Infliximab on bioZen 1.8 µm SEC-3
24764
Separation Mode: Gel Filtration Chromatography (GFC)
Gel Filtration Chromatography (GFC)
SEC-3
HPLC
Pharmaceutical/Biopharmaceutical
Life Science
Therapeutic / Clinical
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 24764)
Column: |
Brand Name: bioZen |
Part No: |
Phase Name: SEC-3 |
Similar Applications
search
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide